• Image
  • Image
  • Image
  • Image

2020 Vascular Inflammation Co-Organizer

Vote for the Co-Organizer of the
2020 Vascular Inflammation Workshop

Voting will take place onsite at Vascular Biology 2018 via the meeting mobile app.
Select one candidate.  Click on the name to see a brief bio and their goals for the meeting. 

It will be necessary for you to log-in in order to cast your vote.

The Organizer of this workshop is William Muller, Northwestern University Feinberg School of Medicine. The chosen candidate will co-organize with Dr. Muller in 2020 and will be the Organizer for the 2023 Workshop.

Gwendalyn J. Randolph, Washington University in St Louis

Gwendalyn J. Randolph, PhD
Emil R. Unanue Distinguished Professor
Dept of Pathology & Immunology
Head, Immunology Graduate Program
Washington University School of Medicine
Washington University in St Louis


GwenRandolphHeadShot 145x200

Gwendalyn J. Randolph obtained her bachelor's degree in Biology from Temple University and PhD in Molecular and Cellular Pathology from State University of New York at Stony Brook, working with Martha Furie. She then carried out postdoctoral studies at Rockefeller University and Weill Medical School of Cornell University under the mentorship of Bill Muller and Ralph Steinman. She spent 11 years on the faculty at Mount Sinai School of School of Medicine in New York before relocating to Washington University in 2011. She is currently the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology at Washington University in St. Louis. She is also the Director of the Immunology Graduate Program at Washington University. Her awards include the NIH Director’s Pioneer Award (2015) and NIH MERIT Award (2016). Her laboratory considers how the transit of cells (eg., monocytes and dendritic cells) and molecules (eg., lipoproteins) out of tissue influences the inflammatory microenvironment. Her work considering cellular and molecular clearance through lymphatics has fostered key contributions to understanding the pathogenesis of atherosclerosis, with recent effort in her laboratory shifting to consider inflammatory bowel diseases.


, I am an active member of NAVBO, serving on the Education Committee, past organizer of Vasculata (2018), and have had the fortune and pleasure to be part of the Vascular Inflammation workshop since the first presentation. 


As co-organizer, I would aim to continue to bring together the vascular inflammation community that has come to rely on the quality and importance of the meeting to their work, while also aiming to bring in new speakers and topics at the forefront of this interdisciplinary field. It would be wonderful to have the opportunity to showcase the outstanding work unfolding in vascular inflammation.

Ira Tabas, Columbia University

Ira Tabas, M.D., Ph.D.
Richard J. Stock Professor
Department of Medicine
Professor of Pathology & Cell Biology (in Physiology and Cellular Biophysics)
Columbia University


Tabas photoCropped

Dr. Tabas is the Richard J. Stock Professor of Medicine, Cell Biology, and Physiology at Columbia University Medical Center (CUMC). He received his M.D. and Ph.D. (Biochemistry) degrees from Washington University in St. Louis and completed his Internal Medicine and Endocrinology/ Metabolism training at CUMC, with board certification in both disciplines. His research focuses on cardiometabolic disease, with a long history of work in the area of molecular-cellular mechanisms of advanced atherosclerosis. His research has elucidated roles of macrophage endoplasmic reticulum (ER) stress, apoptosis, defective efferocytosis, and defective inflammation resolution in advanced plaque progression. Over the last ten years, Dr. Tabas' laboratory has expanded its interests into an area that is a major driving force behind atherosclerosis, namely, obesity-associated type 2 diabetes (T2D). In particular, the laboratory has discovered a new calcium-ER stress signaling pathway in hepatocytes that contributes to the metabolic disturbances of obesity and diabetes. In both the atherosclerosis and metabolism areas, there is strong emphasis on therapeutic translation. He has lectured worldwide and published over 200 original research articles and reviews. These papers have been published in Cell, Nature, Science, Nature Cell Biology, Nature Reviews Immunology, Cell Metabolism, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, and other top journals. Dr. Tabas also serves on the Board of Reviewing Editors for the journal Science. He was elected to both the Society for Clinical Investigation and the Association of American Physicians. Dr. Tabas' other honors include the American Heart Association Established Investigator Award, the Columbia University Doctor Harold and Golden Lamport Research Award, the American Heart Association/ATVB Council Special Recognition Award, the 2011 Alumni Achievement Award from Washington University School of Medicine, the 2014 Society of Leukocyte Biology Bonazinga award, which is the society's highest honor for excellence in leukocyte biology research, the 2015 Harrington Discovery Institute Innovator-Scholar Award for his work in diabetes, and the 2016 American Heart Association Russell Ross Lectureship Award in Vascular Biology.

As a member of NAVBO, I truly enjoy attending the meetings and interacting with colleagues and particularly young scientists.  I find a wonderful complementarity between the work that we do in atherosclerosis, inflammation, and cardiometabolic disease pathophysiology and some of the more traditional areas of interest of NAVBO in vascular biology.

My goals for the 2020 workshop are to continue the tradition of featuring the best mechanistic-based research in vascular inflammation while also making sure that (a) we include a diverse group of presenters and attendees, including young investigators and a good balance of female and male researchers; (b) have ample time for discussion after each talk and also time for informal discussions in between sessions; (c) encourage presentations on disease relevance and translational research, including areas that might be relevant to genomic and precision medicine.